Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| SQ28603；Squibb 28603;SQ28,603 | C13H17NO3S | 100845-83-8 | Details |
| Tiapride hydrochloride | C15H25ClN2O4S | 51012-33-0 | Details |
| Solenopsin | C17H35N | 137038-57-4 | Details |
| Sofosbuvir impurity C | C22H29FN3O9P | 1496552-28-3 | Details |
| Sofosbuvir impurity K | C22H29ClN3O9P | 1496552-51-2 | Details |
| Sirtuin modulator 1 | C31H32ClN5O2S2 | 2070015-26-6 | Details |
| SRT3657 | C40H54N8O6S | 1383551-17-4 | Details |
| SNT-207858 | C32H45Cl4N5O3 | 1104080-42-3 | Details |
| SJB3-019A | C16H8N2O3 | 2070015-29-9 | Details |
| SIRT-IN-2 | C15H21N5O3S2 | 1431411-66-3 | Details |
| Fleroxacin | C17H18F3N3O3 | 79660-72-3 | Details |
| Spirodiclofen | C21H24Cl2O4 | 148477-71-8 | Details |
| STAT3-IN-1 | C28H29NO6 | 2059952-75-7 | Details |
| SMYD3-IN-1 | C28H31ClN4O3 | 2095160-79-3 | Details |
| SMS2-IN-1 | C34H37F6N3O5 | 2098890-15-2 | Details |
| Squalamine；MSI-1256 | C34H65N3O5S | 148717-90-2 | Details |
| SIS3 free base | C28H27N3O3 | 1009104-85-1 | Details |
| Sodium formononetin-3'-sulfonate；Sul-F | C15H9NaO7S | 949021-68-5 | Details |
| Solabegron | C23H23ClN2O3 | 252920-94-8 | Details |
| Sofosbuvir impurity F；Sofosbuvir 3',5'-Bis-(S)-phosphate | C34H45FN4O13P2 | 1337482-17-3 | Details |
| SMAP-2；DT-1154 | C27H27F3N2O4S | 1809068-70-9 | Details |
| Sorafenib-d4；Bay 43-9006 (D4);Sorafenib (D4) | C21H16ClF3N4O3 | 1207560-07-3 | Details |
| BI-3406 | C23H25F3N4O3 | 2230836-55-0 | Details |
| Sigma-1 receptor antagonist 2 | C20H26ClN3O2 | 1639220-15-7 | Details |
| Gatifloxacin | C19H22FN3O4 | 112811-59-3 | Details |
| SK33 | C20H13F9N2O3 | 1928724-23-5 | Details |
| Silvestrol aglycone | C27H26O8 | 960365-65-5 | Details |
| Sofosbuvir impurity J | C22H30FN4O8P | 1334513-10-8 | Details |
| Sofosbuvir impurity G | C22H29FN3O9P | 1337482-15-1 | Details |
| SMN-C3 | C24H28N6O | 1449597-34-5 | Details |
| ST-193 | C24H25N3O | 489416-12-8 | Details |
| Solanidine | C27H43NO | 80-78-4 | Details |
| SIRT5 inhibitor 1 | C31H39FN6O6S2 | 2166487-21-2 | Details |
| SNT-207858 free base | C32H43Cl2N5O3 | 1104662-66-9 | Details |
| ST1936 oxalate | C15H19ClN2O4 | 1782228-83-4 | Details |
| Sodium Channel inhibitor 1 | C24H19F4N3O3 | 1198117-23-5 | Details |
| SSR128129E free acid；SSR free acid | C18H16N2O4 | 848463-13-8 | Details |
| PSI-7976 | C22H29FN3O9P | 1190308-01-0 | Details |
| Soluble epoxide hydrolase inhibitor | C18H12F5N5O3 | 1241826-88-9 | Details |
| SMYD2-IN-1 | C25H25Cl2F2N7O2 | 2023788-96-5 | Details |
| SSTR5 antagonist 1 | C28H34FN3O5 | 1628741-91-2 | Details |
| SNDX-5613 | C32H47FN6O4S | 2169919-21-3 | Details |
| SP-8356 | C18H20O4 | 1454885-45-0 | Details |
| SKF-34288 hydrochloride | C6H6ClNO2S | 320386-54-7 | Details |
| Spiramycin I | C43H74N2O14 | 24916-50-5 | Details |
| NSC-70220；SOS1-IN-1 | C22H15NO2 | 4551-00-2 | Details |
| Sotalol-d6 hydrochloride；Sotalol D6 hydrochloride | C12H21ClN2O3S | 1246820-85-8 | Details |
| Sodium Channel inhibitor 2 | C26H25Cl2N3O | 653573-60-5 | Details |
| SPD304 dihydrochloride | C32H33ClF3N3O2 | 1049741-03-8 | Details |
| Sigma-1 receptor antagonist 3 | C19H23ClFN3O | 1639220-17-9 | Details |
| SOCE inhibitor 1 | C25H22F3N5O4 | 2169316-15-6 | Details |
| SLC13A5-IN-1 | C19H19Cl3N2O3S | 2227548-95-8 | Details |
| Clofibrate；Clofibrato;Ethyl clofibrate;Clofibratum | C12H15ClO3 | 637-07-0 | Details |
| SMP-028 | C23H26FN5O2S | 914389-14-3 | Details |
| Sitaxsentan | C18H15ClN2O6S2 | 184036-34-8 | Details |
| Siguazodan；SKF 94836 | C14H16N6O | 115344-47-3 | Details |
| SN50 | C129H230N36O29S | 213546-53-3 | Details |
| Sofosbuvir impurity M | C22H30N3O10P | 2095551-10-1 | Details |
| 3-Pyridinemethanol | C6H7NO | 100-55-0 | Details |
| Solifenacin D5 hydrochloride | C23H22D5ClN2O2 | 1426174-05-1 | Details |
| SSR-241586 | C32H42Cl2N4O3 | 1239279-30-1 | Details |
| SIAIS178 | C50H62ClN11O6S2 | 2376047-73-1 | Details |
| SKF89976A hydrochloride | C22H26ClNO2 | 85375-15-1 | Details |
| Eugenol | C10H12O2 | 97-53-0 | Details |
| Squalamine lactate；MSI-1256F | C37H71N3O8S | 320725-47-1 | Details |
| SN 2 | C17H21NO | 823218-99-1 | Details |
| Sofosbuvir impurity A | C22H29FN3O9P | 1496552-16-9 | Details |
| Sofosbuvir impurity N | C20H25FN3O9P | 1394157-34-6 | Details |
| 5-HT3 antagonist 2 | C18H21N3O | 128199-93-9 | Details |
| SQ-31765；SQ31765;SQ 31765 | C24H27F3N2O4 | 138383-07-0 | Details |
| Spastazoline | C20H30N8 | 2351882-11-4 | Details |
| Sigma-1 receptor antagonist 1 | C19H23Cl2N3O | 1639220-19-1 | Details |
| Sodium copper chlorophyllin B | C34H29CuN4NaO7(-2) | 28302-36-5 | Details |
| Sparfosic acid trisodium | C6H11NNaO8P | 70962-66-2 | Details |
| SID 26681509 | C27H33N5O5S | 958772-66-2 | Details |
| Siltenzepine | C19H20ClN3O4 | 98374-54-0 | Details |
| SK1-IN-1 | C22H30N4O3 | 1218816-71-7 | Details |
| SR121566A | C20H25N5O4S | 180144-61-0 | Details |
| SNT-207707 | C32H44ClN5O | 1064662-40-3 | Details |
| SIRT-IN-1 | C19H27N5O2S | 1431411-60-7 | Details |
| SP4206 | C30H37Cl2N7O6 | 515846-21-6 | Details |
| SSTC3 | C23H17F3N4O3S2 | 1242422-09-8 | Details |
| ST3932 | C12H16N8O | 1246018-21-2 | Details |
| SIBA | C14H21N5O3S | 35899-54-8 | Details |
| SPL-410 | C24H31F3N2O4S | 2351886-00-3 | Details |
| Src Inhibitor 3 | C34H32ClFN8O4 | 2380027-49-4 | Details |
| SM-276001 | C16H21N7O | 473930-22-2 | Details |
| SMS1-IN-1 | C23H23BrN2O4S | 1807943-38-9 | Details |
| Cisapride | C23H29ClFN3O4 | 81098-60-4 | Details |
| Siomycin A | C71H81N19O18S5 | 12656-09-6 | Details |
| Sootepin D | C31H48O4 | 1154518-97-4 | Details |
| SR10067 | C31H31NO3 | 1380548-02-6 | Details |
| Soraprazan；BYK61359 | C21H25N3O3 | 261944-46-1 | Details |
| sPLA2-X Inhibitor 31 | C19H15F3N2O4 | 2241025-50-1 | Details |
| Sirt2-IN-1 | C28H27N7O2S2 | 1862238-00-3 | Details |
| Silvestrol aglycone (enantiomer) | C27H26O8 | 1112993-18-6 | Details |
| 4-Aminosalicylic acid；Aminopar;Aminosalicylic acid;para-aminosalicylic acid;4-aminosalicylate | C7H7NO3 | 65-49-6 | Details |
| Sodium citrate dihydrate | C6H9Na3O9 | 6132-04-3 | Details |
| Sitravatinib malate；MGCD516 malate;MG-516 malate | C37H35F2N5O9S | 2244864-88-6 | Details |
| Sodium laureth sulfate | (C2H4O)nC12H26O4S.Na | 9004-82-4 | Details |
| Product Total： Product Page： | ||||
| 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 | ||||